ACTH-secreting atypical carcinoid lung tumour expanding the Lynch syndrome spectrum

Lynch syndrome is a genetic condition associated with tumours of the colon, reproductive organs, and urinary tract. Less commonly, neuro-endocrine tumours have also been reported. We describe the first case of a Lynch syndrome patient presenting with a neuroendocrine lung tumour manifesting as cortisol excess (Cushing’s syndrome) in a middle-aged woman. In addition to the […]

Read More…

Expert endoscopic surveillance in CDH1 pathogenic variant carriers seems safe, even after positive (pT1a) biopsies

In this retrospective study, Patrick Benusiglio and colleagues show that expert surveillance is safe in the hereditary diffuse gastric cancer syndrome. Among 20 CDH1 pathogenic variant carriers undergoing annual upper gastrointestinal endoscopy, none has developed aggressive signet ring cell carcinoma of the stomach, regardless of the presence of intramucosal (pT1a) cancer foci on biopsies. This […]

Read More…

Advancing genotype-phenotype analysis through 3D facial morphometry: insights from Cri-du-Chat syndrome

Cri-du-Chat Syndrome (CdCS) is a rare genetic disorder caused by missing pieces (deletions) of chromosome 5. This study compared 3D facial photos of 29 individuals with CdCS and thousands of unaffected individuals to understand how different deletions affect facial features. Large deletions caused consistent features like a short space between the nose and upper lip, […]

Read More…

Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer

The Manchester score-(MS) was developed-(2004) to assess the likelihood of BRCA1/2 pathogenic variants-(PV) in breast/ovarian cancer cases with MS=15/20 being the threshold for 10/20% detection rates. We have now evaluated MS in >10,000 breast/ovarian cancers. Overall, 6744 breast and 3291 ovarian cases were tested. For breast, 453-(6.7%) PVs were detected in BRCA1 and 456-(6.8%) in […]

Read More…

Analysis of muscle and blood RNA samples from patients with myotonic dystrophy type 1 reveals the presence of new mis-splicing biomarkers of disease severity

Myotonic dystrophy type 1 is a progressive hereditary disease mainly affecting muscles, eyes, brain, among other tissues, which impact patient´s daily lives. Although there is no cure for the disease, much progress is being done to find a treatment. For this, it is required to identify biomarkers, which are molecules or compounds that indicates something […]

Read More…

Dental Agenesis as a Novel Phenotypic Feature Associated with Hereditary Diffuse Gastric Cancer in China

Hereditary diffuse gastric cancer (HDGC) is a rare hereditary disease of gastric cancer caused by germline variants in the CDH1 gene. In our study of 121 Chinese patients with gastric cancer, we identified three individuals carrying CDH1 mutations. Two of them also presented with congenital tooth agenesis, a feature rarely documented in HDGC, particularly in East Asian populations. This observation suggests […]

Read More…

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation

Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a rare and severe blistering skin disorder caused by a genetic mutation in the type VII collagen gene (COL7A1). The COL7A1 c.6527insC mutation is present worldwide and a Sephardic origin of this prevalent mutation has been suggested. In this study, RDEB individuals with the COL7A1 c.6527insC mutation from Spain, […]

Read More…

The Genetics Behind Nanophthalmos

Our study investigated the genetic causes of nanophthalmos, a rare condition where eyes are abnormally small, often leading to severe vision problems. We analyzed the genes of 105 Chinese patients, the largest group of this kind studied so far. Our research found genetic causes in over 70% of patients, primarily in four genes: PRSS56, MFRP, […]

Read More…

Heterozygous TBX2 frameshift variants cause a novel syndromic hearing loss with incompletely penetrant nystagmus

Tbx2 is a transcription factor critical to inner hair cell specification and maintenance during murine cochlear development. However, its pathogenic role in human genetic hearing loss remains uncharacterized. In this study, we identified two heterozygous TBX2 frameshift variants in two unrelated families with hearing loss associated with incomplete penetrance nystagmus, via a combination of linkage […]

Read More…